Clinical Immunoanalyzer Market: Introduction

  • Clinical immunoanalyzer is a diagnostic device used to detect specific analytes in blood or in fluids by employing immunoassay processes such as chemiluminescence immunoassay, enzyme linked fluorescent immunoassay, enzyme linked immunosorbent assay, and radioimmunoassay (RIA). An immunoanalyzer comprises washer, reagent dispenser, auto sampler, and the offered product depending upon the configuration and test options. Few clinical immunoanalyzer products use automated chemical analyzer, which reduces manual intervention and improves the workflow. These clinical immunoanalyzers are utilized in hospitals and laboratories for the detection of bacterial infections and viral toxins. These are also employed in drug monitoring, allergy testing, as cancer markers, and in detecting toxins.

Clinical Immunoanalyzer Market: Key Trends

  • High prevalence and incidence rates of chronic and infectious diseases is estimated to drive the demand for clinical immunoanalyzers. Prevalence of infectious and chronic diseases across the globe drives the demand for early diagnosis. Hence, diagnosis of infectious diseases is one of the leading applications of clinical immunoanalyzers. Furthermore, investment in the development of new assays for diagnosis of various infectious diseases has been increasing. In April 2017, the U.S. Department of Health and Human Services awarded US$ 8.9 million to Siemens Healthineers for the development of Zika virus immunoassay test to be used on its Advia platform of immunoassay analyzers. High prevalence of infectious diseases is projected to propel the demand for diagnostic tests. Demand for clinical immunoanalyzers is likely to increase owing to its benefits in monitoring transfusion medicine, such as blood transfusion and organ transplant. Moreover, incidence of endocrinology diseases, such as thyroid dysfunction, diabetes mellitus, and the incidences of osteoporosis is rising owing to changing lifestyles. This is likely to boost the demand for clinical immunoanalyzers.
  • The world is presently struggling with the COVID-19 pandemic. COVID-19 leads to pneumonia, severe & acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. The global clinical immunoanalyzer market has expanded at a rapid pace during the pandemic.
  • Governments of developing countries are making significant investments to modernize healthcare infrastructure in their respective countries, which is likely to increase access to healthcare. This is expected to fuel the demand for clinical immunoanalyzer. Rise in prevalence of chronic heart diseases, especially heart attack, in developing countries presents lucrative opportunities in the global clinical immunoanalyzer market.

North America to Capture Major Share of Global Clinical Immunoanalyzer Market

  • North America is projected to account for a notable share of the global clinical immunoanalyzer market during the forecast period owing to the increasing knowledge on biomarkers of various chronic diseases, which has prompted industry experts and researchers to apply this information in the development of new assays to expand the applications of automated immunoassay analyzers. Development in the fields of genomics and proteomics has expanded the database of biomarkers used by industry players to develop new assays. For instance, a chemiluminescence assay has been developed to test vitamin D deficiency, which was earlier diagnosed through manual ELISA methods. New molecular diagnostic tests are being developed for infectious diseases. Such developments in the region boost the market during the forecast period.
  • The clinical immunoanalyzer market in Europe is likely to expand at a rapid pace during the forecast period, owing to an increase in research & development on clinical immunoanalyzer in the region. The clinical immunoanalyzer market in Asia Pacific is expected to expand at a high CAGR during the forecast period driven by increased prevalence and incidence rates of chronic and infectious diseases in countries, such as China and India, and rapid adoption of research technologies. The market in Middle East & Africa and Latin America is anticipated to expand during the forecast period due to an increase in incidence of chronic diseases in these regions.

Key Players Operating in Global Clinical Immunoanalyzer Market

Strategies adopted by the key players such as mergers & acquisitions, partnerships, joint ventures, and agreements are projected to boost the global clinical immunoanalyzer market. Key players hold a major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global clinical immunoanalyzer market.

Major players operating in the global clinical immunoanalyzer market are listed below:

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Siemens Healthineers
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Werfen Life
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Randox Laboratories

Global Clinical Immunoanalyzer Market: Research Scope

Global Clinical Immunoanalyzer Market, by Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme Linked Fluorescent Immunoassay (ELFA)
  • Enzyme Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Others

Global Clinical Immunoanalyzer Market, by Application

  • Cancer Markers
  • Infectious Diseases
  • Cardiac Disease
  • Drug Monitoring
  • Others

Global Clinical Immunoanalyzer Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Others

Global Clinical Immunoanalyzer Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Clinical Immunoanalyzer Market